Industry
Medical Supply Manufacturers companies
VCMC tracks 41,245 companies in Medical Supply Manufacturers. 1,552 of them have raised a venture or growth round, $55.94B in total, with a median round of $10M; 674 raised since 2024. 1,519 of the 1,552 have a VCMC valuation; the median is $51.4M.
41,245
companies tracked
1,552
venture-backed
4% of those tracked
$55.94B
raised in total
by 1,455 companies
$10M
median round
of 2,080 rounds with an amount
$51.4M
median valuation
of 1,519 companies valued
Values cover private companies only; public companies are not included.
By their latest round, most are at Seed (431 of 1,552).
- Pre-seed 72
- Seed 431
- Series A 431
- Series B 252
- Series C and later 349
- Stage not stated 17
The companies
Medical Supply Manufacturers companies
The 50 venture-backed companies below are this page's list; CMR Surgical has raised the most ($1.76B).
| # | Last round | History | Range | Trend | Grade | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CMR Surgical Cambridge, United Kingdom | Growth Equity Oct 2026 $400M | $3.5B | $2.5B – $5.5B | $3.9B (+10%) | $379M | 0% | 666 | flat | B | |
| 2 | MiRus Marietta, United States | Growth Equity May 2026 $1.50B | $17.5B | $11.1B – $28.2B | $18.5B (+6%) | $1.7B | 0% | 135 | up | B | |
| 3 | Oura Oulu, Finland | Series E Sep 2025 $875M | $15.7B | $9.7B – $18.1B | $15.7B (0%) | $1.9B | 0% | 1,617 | growing | B | |
| 4 | Neuralink Fremont, United States | Series E Jun 2025 $650M | $13.1B | $8.1B – $15.1B | $13.1B (0%) | $1.4B | 0% | 672 | up | B | |
| 5 | Cornerstone Robotics Waltham, United States | Growth Equity Sep 2026 $700M | $4.5B | $3.1B – $6.9B | $4.9B (+9%) | $438M | 0% | 63 | unknown | B | |
| 6 | WHOOP Boston, United States | Series G Mar 2026 $575M | $12.1B | $8.8B – $15.9B | $13.8B (+14%) | $1.5B | 0% | 1,649 | growing | A | |
| 7 | Insightec Tirat HaCarmel, Israel | Growth Equity Jun 2024 $150M | $1.5B | $412M – $2.4B | $1.2B (-20%) | $170M | 4% | 541 | flat | C | |
| 8 | Imperative Care Campbell, United States | Debt Mar 2026 $100M | $2.6B | $1.0B – $4.0B | $2.2B (-18%) | $289M | 0% | 421 | up | C | |
| 9 | RefleXion Hayward, United States | Growth Equity Nov 2023 $105M | $384M | $219M – $888M | $211M (-45%) | $98.8M | 97% | 123 | shrinking | C | |
| 10 | South Korea | Series G Dec 2020 $226M | $731M | $131M – $2.6B | $647M (-11%) | $316M | 50% | 49 | up | D | |
| 11 | Singapore | Series B Jan 2022 $100M | $6.21M | $0 – $6.21M | $6.21M (0%) | – | 100% | 46 | unknown | dead | |
| 12 | Sant Quirze del Vallès, Spain | Growth Equity Sep 2026 $56M | $575M | $375M – $956M | $628M (+9%) | $61.6M | 0% | 45 | up | B | |
| 13 | Awans, Belgium | Series E Sep 2020 $29M | $262M | $14.2M – $601M | $262M (0%) | $50.8M | 0% | 7 | unknown | D | |
| 14 | Wavre, Belgium | Series C Sep 2019 $44M | $68.0M | $24.1M – $429M | $68.0M (0%) | $57.2M | 97% | 38 | down | D | |
| 15 | Singapore | Series B Sep 2023 $20M | $196M | $24.1M – $298M | $196M (0%) | $24.8M | 0% | 5 | unknown | D | |
| 16 | Danderyd, Sweden | Growth Equity Oct 2019 $38M | $109M | $21.6M – $382M | $109M (0%) | $41.5M | 59% | 87 | flat | D | |
| 17 | Casablanca, Morocco | Debt Dec 2025 $8.5M | $255M | $45.2M – $552M | $251M (-2%) | $40.1M | 0% | 309 | up | D | |
| 18 | Eskilstuna kommun, Sweden | Growth Equity Nov 2023 $41M | $473M | $131M – $729M | $358M (-24%) | $47.0M | 1% | 113 | up | C | |
| 19 | Awans, Belgium | Other Jan 2026 $24M | $150M | $51.8M – $252M | $94.9M (-37%) | $20.3M | 15% | 62 | up | C | |
| 20 | Alcobendas, Spain | Other Apr 2025 $21M | $85.9M | $7.41M – $201M | $82.0M (-4%) | $19.1M | 15% | 46 | up | D | |
| 21 | Solna, Sweden | Grant Mar 2023 $1.0M | $114M | $9.38M – $256M | $102M (-10%) | $32.5M | 17% | 30 | flat | D | |
| 22 | Skin Analytics London, United Kingdom | Series B Apr 2025 $20M | $113M | $68.2M – $130M | $113M (0%) | $13.6M | 0% | 125 | growing | B | |
| 23 | Louvain-la-Neuve, Belgium | Series A Mar 2026 $11M | $81.4M | $38.2M – $159M | $105M (+29%) | $16.0M | 0% | 34 | up | C | |
| 24 | Singapore | Series B Mar 2024 $24M | $246M | $40.6M – $375M | $192M (-22%) | $31.2M | 0% | 45 | flat | D | |
| 25 | Mont-Saint-Guibert, Belgium | Series B Jan 2023 $14M | $18.3M | $9.07M – $57.2M | $11.0M (-40%) | $13.8M | 97% | 17 | shrinking | C | |
| 26 | Wilmington, United States | Series A Aug 2025 $24M | $252M | $94.9M – $384M | $252M (0%) | $35.3M | 0% | 19 | growing | C | |
| 27 | Norway | Series A Aug 2020 $19M | $127M | $4.63M – $258M | $127M (0%) | $25.9M | 0% | 10 | unknown | D | |
| 28 | Faenza, Italy | Series B Apr 2021 $12M | $14.7M | $4.85M – $103M | $14.0M (-5%) | $14.1M | 95% | 21 | down | D | |
| 29 | Awans, Belgium | Series B Jul 2019 $7.9M | $44.5M | $2.92M – $78.9M | $44.4M (0%) | $9.31M | 0% | 25 | flat | D | |
| 30 | Teià, Spain | Series A Jun 2025 $16M | $151M | $52.8M – $229M | $151M (0%) | $23.0M | 0% | 29 | up | C | |
| 31 | Christchurch, New Zealand | Series A Jan 2026 $15M | $117M | $49.0M – $204M | $134M (+15%) | $21.6M | 0% | 24 | growing | C | |
| 32 | China, Mexico | Series B Oct 2022 $14M | $121M | $8.84M – $184M | $121M (0%) | $16.2M | 0% | 2 | unknown | D | |
| 33 | Moreira, Portugal | Series C Feb 2005 $12M | $31.2M | $5.25M – $133M | $31.2M (0%) | $15.7M | 54% | 29 | down | D | |
| 34 | Odense, Denmark | Series B Sep 2018 $12M | $30.7M | $5.33M – $116M | $30.7M (0%) | $14.1M | 59% | 30 | up | D | |
| 35 | Certaldo, Italy | Series B Jul 2021 $9.7M | $38.2M | $3.32M – $91.0M | $35.2M (-8%) | $10.4M | 20% | 18 | flat | D | |
| 36 | Poznań, Poland | Series A Nov 2023 $5.8M | $61.7M | $7.51M – $87.5M | $49.1M (-20%) | $9.41M | 0% | 75 | flat | D | |
| 37 | San Lazzaro di Savena, Italy | Series A Feb 2023 $7.4M | $56.1M | $6.79M – $108M | $52.0M (-7%) | $11.5M | 8% | 52 | up | D | |
| 38 | Turku, Finland | Series A Jan 2024 $10M | $56.1M | $15.0M – $134M | $39.9M (-29%) | $14.1M | 42% | 34 | up | D | |
| 39 | Incheon, South Korea | Series B Oct 2021 $10M | $64.6M | $2.83M – $142M | $64.6M (0%) | $11.8M | 0% | 9 | unknown | D | |
| 40 | Gosselies, Belgium | Series D Jan 2021 $9.5M | $123M | $13.8M – $239M | $118M (-4%) | $21.2M | 0% | 36 | up | D | |
| 41 | Almada, Portugal | Seed Jan 2023 $5.2M | $56.7M | $4.53M – $117M | $55.7M (-2%) | $15.2M | 0% | 17 | up | D | |
| 42 | Bratislava, Slovakia | Grant Jul 2024 $3.2M | $3.51M | $0.23M – $8.09M | $3.36M (-4%) | $1.41M | 22% | 18 | down | D | |
| 43 | Daejeon, South Korea | Series A Dec 2024 $7.8M | $49.4M | $14.5M – $90.0M | $41.4M (-16%) | $10.9M | 40% | 14 | flat | C | |
| 44 | Mawson Lakes, Australia | Series A Jan 2023 $7.7M | $50.4M | $14.8M – $106M | $48.6M (-4%) | $11.7M | 10% | 19 | growing | C | |
| 45 | Klosterneuburg, Austria | Seed Nov 2022 $7.3M | $6.38M | $3.40M – $15.0M | $4.23M (-34%) | $11.8M | 97% | 8 | shrinking | C | |
| 46 | Wellington, New Zealand | Pre-Seed Feb 2026 $7.3M | $74.3M | $34.3M – $139M | $87.3M (+17%) | $21.6M | 19% | 23 | growing | C | |
| 47 | Singapore | Seed Aug 2024 $7.0M | $50.3M | $13.6M – $95.8M | $36.9M (-27%) | $16.6M | 39% | 16 | up | C | |
| 48 | Norway | Seed Dec 2020 $6.8M | $32.9M | $2.48M – $94.5M | $32.7M (0%) | $16.3M | 30% | 12 | flat | D | |
| 49 | Kaunas, Lithuania | Seed Jan 2024 $6.6M | $92.6M | $27.5M – $141M | $72.0M (-22%) | $18.2M | 0% | 41 | growing | C | |
| 50 | Norway | Series A Jul 2023 $6.5M | $9.84M | $5.15M – $25.0M | $5.91M (-40%) | $8.56M | 97% | 14 | shrinking | C |
Showing 50 of 41,245. Load more lists every other company here, 50 at a time.
Valuations
How these companies are valued
1,519 of the 1,552 venture-backed companies here have a VCMC valuation; the median is $51.4M. A company acquired after its last round keeps its last value as a private company and is left out of the median. 51 companies have disclosed a valuation; for the rest VCMC's valuation is the only number. Each valuation comes with a range, from a low to a high scenario, and a prediction for a year from now. Values cover private companies only; public companies are not included. How VCMC values companies.
Investors
Who backs them
Firms that backed two or more of these companies. Bpifrance backed 23, High-Tech Gründerfonds 21.
- Bpifrance 23 companies, led 2
- 21 companies, led 5
- 21 companies, led 4
- EQT 19 companies, led 7
- 19 companies, led 5
- EIC Fund 19 companies, led 1
- 17 companies, led 13
- Khosla Ventures 17 companies, led 8
- 16 companies, led 14
- Zürcher Kantonalbank 16 companies
- 15 companies, led 10
- 15 companies, led 9
Recent rounds
Latest funding
233 rounds from Oct 2025 to Sep 2026, $8.48B with a disclosed amount.
- Series D, led by Pershing Square Inc. and Ackman Oxman Institute $250M 24 Sep 2026
- Pre-seed, with Techstars and Catalyst OrthoScience $10M 24 Sep 2026
- Growth, led by Omega Funds $56M 23 Sep 2026
- Growth, with Andera Partners and Sofinnova Partners $90M 23 Sep 2026
- Growth, led by 1315 Capital amount not disclosed 23 Sep 2026
- Series A, led by XGEN Venture $17M 22 Sep 2026
- Series A, led by .406 Ventures $22M 22 Sep 2026
- Growth, led by Catalio Capital Management $45M 20 Sep 2026
- Growth, led by Swisscanto (CH) Private Equity Switzerland Growth II L-QIF KmGK and Swisscanto $25M 18 Sep 2026
- Series B, with Asahi Kasei Medical and Rapha Capital Management $20M 17 Sep 2026
- Series A, with Shorewind Capital and Great Oaks Venture Capital $10M 15 Sep 2026
- Seed, led by Talents Fund $1.5M 15 Sep 2026
Browse
Related groups
Medical Supply Manufacturers by city
Medical Supply Manufacturers by country
Other industries
Questions
Frequently asked
How many medical Supply Manufacturers companies does VCMC track?
41,245. 1,552 of them have raised a venture or growth round.
How much have medical Supply Manufacturers companies raised?
$55.94B in total across the 1,455 with a known amount; the median round is $10M. 674 raised a round since 2024.
Which medical Supply Manufacturers companies have raised the most?
CMR Surgical ($1.76B), MiRus ($1.56B), Oura ($1.46B).
Which investors back medical Supply Manufacturers companies most often?
Bpifrance (23 companies), High-Tech Gründerfonds (21 companies), ShangBay Capital (21 companies).
What are medical Supply Manufacturers companies worth?
The median VCMC valuation is $51.4M across 1,519 companies; companies acquired after their last round are left out. Values cover private companies only; public companies are not included.
What was the latest funding round?
Precision Neuroscience raised a Series D round of $250M (Sep 2026), led by Pershing Square Inc. and Ackman Oxman Institute.